Johannes Hüsing - Concepedia

Author

Johannes Hüsing

Also Known As

D. Czaja, Hüsing, J., Hüsing, Johannes, Hüsing, Johannes Otto, J Hüsing, J. Husing, J. Hüsing, J. O. Hüsing, JOHANNES HÜSING, Johannes Husing

103

Publications

Citations

H-Index

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg Essen University Hospital Institut für Medizinische Informatik, Biometrie und Epidemiologie University of Duisburg-Essen

About

Johannes Hüsing is an author at Heidelberg University specializing in medicine, radiation oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	2K
2	Health Sciences	3	3	418
3	Engineering	1	1	328
4	Public Health	1	1	61
5	Anesthesia	1	1	54

Johannes Hüsing

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Early detection of acute renal failure by serum cystatin C Stefan Herget‐Rosenthal, G. Marggraf, Johannes Hüsing, Kidney International GlomerulonephritisUrologyRenal FunctionKidney FailureChronic Kidney Disease	2004	885
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial Thorsten Steiner, Sven Poli, Martin Griebe, The Lancet Neurology ThrombosisIntracranial HaemorrhageMedicineRandomised TrialHematology	2016	366
Worldwide Ethnic Distribution of the G Protein β3 Subunit 825T Allele and Its Association with Obesity in Caucasian, Chinese, and Black African Individuals Winfried Siffert, Peter Forster, Karl‐Heinz Jöckel, Journal of the American Society of Nephrology	1999	333
Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Frank Tschentscher, Johannes Hüsing, Tanja Hölter, PubMed EngineeringGeneticsPathologyOligonucleotide MicroarraysDermatology	2003	328
<i>MGMT</i> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, Clinical Cancer Research	2015	311
Prognostic Value of Tubular Proteinuria and Enzymuria in Nonoliguric Acute Tubular Necrosis Stefan Herget‐Rosenthal, Dennis Poppen, Johannes Hüsing, Clinical Chemistry	2004	275
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial Karsten Geletneky, Jacek Hajda, Assia L. Angelova, Molecular Therapy	2017	249
Accelerometry of Adductor Pollicis Muscle Predicts Recovery of Neuromuscular Blockade in Anesthetized Patients Matthias Eikermann, Harald Groeben, Johannes Hüsing, Anesthesiology	2003	215
Loss of molars in periodontally treated patients: a retrospective analysis five years or more after active periodontal treatment Bettina Dannewitz, Jörg Krieger, Johannes Hüsing, Journal Of Clinical Periodontology	2005	146
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma Nina Wagener, Stephan Macher‐Goeppinger, Maria Pritsch, BMC Cancer	2010	143

Page 1